Edition:
United States

Masimo Corp (MASI.OQ)

MASI.OQ on NASDAQ Stock Exchange Global Select Market

87.22USD
3:59pm EST
Change (% chg)

$0.36 (+0.41%)
Prev Close
$86.86
Open
$87.05
Day's High
$87.83
Day's Low
$86.51
Volume
141,291
Avg. Vol
163,883
52-wk High
$104.71
52-wk Low
$66.35

Latest Key Developments (Source: Significant Developments)

Masimo reports Q3 earnings per share $0.70
Tuesday, 31 Oct 2017 04:05pm EDT 

Oct 31 (Reuters) - Masimo Corp ::Masimo reports third quarter 2017 financial results.Sees FY 2017 earnings per share about $2.95.Q3 earnings per share $0.70.Sees FY 2017 revenue about $774 million.Q3 earnings per share view $0.53 -- Thomson Reuters I/B/E/S.Masimo Corp qtrly ‍total revenue, including royalty and other revenue increased 15.6% to $193.7 million​.Masimo Corp says ‍now expects fiscal 2017 earnings per diluted share to be approximately $2.95​.  Full Article

‍San Diego bankruptcy court issues final judgment on Masimo Corp
Monday, 16 Oct 2017 04:15pm EDT 

Oct 16 (Reuters) - Masimo Corp :Masimo Corp - ‍Bankruptcy court in San Diego has issued final judgment, holding that "Sotera Wireless employees misappropriated Masimo trade secrets"​.  Full Article

Masimo Corp appoints Executive Vice President, Chief Financial Officer
Monday, 25 Sep 2017 09:30am EDT 

Sept 25 (Reuters) - Masimo Corp ::Masimo Corp - On Sept. 22, 2017, co appointed Micah Young as company's Executive Vice President, Chief Financial Officer, effective October 16, 2017.Masimo Corp - Young succeeds Mark de Raad, who has served as company's Executive Vice President, Chief Financial Officer since June 2006.  Full Article

Masimo says CFO Mark De Raad to retire ‍​
Thursday, 24 Aug 2017 05:24pm EDT 

Aug 24 (Reuters) - Masimo Corp :Masimo Corp - On August 23, Mark P. De Raad, CFO, notified co of his intention to retire and resign from his roles with the company‍​ ‍​.Masimo Corp - ‍ De Raad has agreed to remain with company through december 30, 2017 - SEC filing​.  Full Article

Masimo Q2 earnings per share $0.83
Wednesday, 2 Aug 2017 04:05pm EDT 

Aug 2 (Reuters) - Masimo Corp ::Masimo reports second quarter 2017 financial results.Sees fy 2017 earnings per share about $2.80.Q2 earnings per share $0.83.Sees fy 2017 revenue about $769 million.Q2 revenue $192.9 million versus i/b/e/s view $189 million.Q2 earnings per share view $0.71 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.66, revenue view $759.4 million -- Thomson Reuters I/B/E/S.  Full Article

Masimo sees 2017 revenue about $759 mln
Wednesday, 3 May 2017 04:05pm EDT 

May 3 (Reuters) - Masimo Corp :Masimo reports first quarter 2017 financial results.Sees fy 2017 earnings per share about $2.65.Q1 earnings per share $0.82.Sees fy 2017 revenue about $759 million.Q1 revenue $186.3 million versus i/b/e/s view $184.1 million.Q1 earnings per share view $0.60 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $2.33, revenue view $753.1 million -- Thomson Reuters I/B/E/S.  Full Article

Masimo announces amendment to settlement agreement between company and Nellcor
Friday, 2 Sep 2016 09:00am EDT 

Masimo Corp: Announced an amendment to existing settlement agreement initially reached between Masimo and Nellcor in January 2006 .Under amendment, Medtronic will continue to pay co royalty of 7.75% for current pulse oximetry products sold in U.S. through October 6, 2018.  Full Article

Masimo Corp reports Q2 GAAP earnings per share $0.57
Wednesday, 3 Aug 2016 04:05pm EDT 

Masimo Corp : Sees FY 2016 revenue about $689 million . Q2 earnings per share view $0.41 -- Thomson Reuters I/B/E/S . Masimo reports second quarter 2016 financial results . Q2 GAAP earnings per share $0.57 . Q2 revenue $172.6 million versus I/B/E/S view $166 million . Sees FY 2016 gaap earnings per share $2.01 .FY 2016 earnings per share view $1.83, revenue view $678.1 million -- Thomson Reuters I/B/E/S.  Full Article

Masimo Corp gives FY 2016 guidance
Tuesday, 23 Feb 2016 04:05pm EST 

Masimo Corp:Expects FY 2016 total product revenues to be approximately $670.0 million including approximately $640.0 million in product revenues and $30.0 million in royalty revenues.expects FY 2016 GAAP earnings per diluted share to be approximately $1.69.Due to the impact of foreign exchange rates and various other non-GAAP adjustments, Masimo also expects FY 2016 non-GAAP earnings per diluted share to be approximately $1.74.  Full Article

BRIEF-Masimo ‍announces FDA clearance and U.S. release Of full family of NomoLine capnography sampling lines​

* ‍ANNOUNCES FDA CLEARANCE AND U.S. RELEASE OF FULL FAMILY OF NOMOLINE CAPNOGRAPHY SAMPLING LINES​ Source text for Eikon: Further company coverage: